	自己資本および準備金		日付
Alaunos Therapeutics	USD 1.29M	865K	2026-03
Amgen	USD 9.19B	532M	2026-03
AstraZeneca	USD 47.33B	1.33B	2026-03
Baxter International	USD 6.04B	86M	2026-03
Biogen	USD 18.65B	394.9M	2026-03
Bioline Rx	USD 19.53M	537K	2025-09
Bristol-Myers Squibb	USD 20.07B	1.6B	2026-03
Celltrion	KRW 435.96B	16.26T	2025-12
Corcept Therapeutics	USD 637.99M	9.82M	2026-03
Cspc Pharmaceutical	CNY 33.18B	71.46M	2025-12
Curis	USD 5.46M	19.45M	2025-12
Deva Holding AS	TRY 5.79B	604.07M	2023-09
Dianthus Therapeutics	USD 1.2B	707.91M	2026-03
Divis Laboratories Ltd	INR 154.13B	4.44B	2025-09
Gilead Sciences	USD 23.52B	897M	2026-03
GlaxoSmithKline	GBP 17.42B	1.05B	2026-03
Incyte	USD 5.62B	455.37M	2026-03
Intrexon	USD 43.17M	75.33M	2024-06
Ionis Pharmaceuticals	USD 491.41M	2.32M	2026-03
J&J	USD 81.19B	358M	2026-03
Kangmei Pharma	CNY 7.22B	504.3M	2025-09
Karyopharm Therapeutics	USD -292.93M	23.67M	2025-12
Knight Therapeutics	CAD 767.27M	480K	2025-12
Laboratorios Farma	EUR 539.39M	22.74M	2023-12
Malin Corporation	EUR 193.2M	75M	2024-12
Medical Developments International	AUD 54.77M	335K	2025-12
Merck	USD 45.88B	6.73B	2026-03
Neuren Pharmaceuticals	AUD 338.45M	15.18M	2025-12
Novartis	USD 38.93B	7.2B	2026-03
Organigram Holdings	CAD 369.46M	20.33M	2025-12
Ovoca Bio	EUR 1.26M	7.41M	2025-06
Pfizer	USD 90.1B	3.63B	2026-03
Pharma Mar	EUR 249.67M	2.16M	2026-03
PTC Therapeutics	USD -180.46M	24.85M	2026-03
Qiagen NV	USD 3.78B	128.73M	2025-12
Regeneron Pharmaceuticals	USD 31.42B	166.7M	2026-03
Roche Holding	CHF 33.8B	758M	2025-12
Sangamo BioSciences	USD 19.6M	14.7M	2025-06
Sartorius	EUR 2.73B	1.14B	2026-03
Sino Biopharmaceutical	CNY 34B	1.48B	2025-06
TG Therapeutics	USD 583.13M	64.89M	2026-03
Tilray	USD 1.58B	39.08M	2025-09
Verastem	USD 57.2M	72.72M	2025-12
Zealand Pharma A/S	14.83B	331.99M	2025-12
Zz Pientze Pharmaceu	CNY 15.21B	740.32M	2026-03